—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Dr. Reddy’s Laboratories Ltd ADR (RDY) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 49 out of 100 (momentum 65 · quality 41 · valuation 57), as of 2026-11-03.
  • Signal: Recovery attempt under the 200-day — Trades +12.3% vs the 50-day and +7.6% vs the 200-day average, 8.9% below the 52-week high and +25.3% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Dr. Reddy’s Laboratories Ltd ADR trades 12.3% above its 50-day and 7.6% above its 200-day moving average. (as of 2026-11-02)

Dr. Reddy's Laboratories makes and sells prescription and over-the-counter medicines, running three segments: Global Generics for branded and generic finished drugs, PSAI for active pharmaceutical ingredients and contract research, and an Others unit developing oncology and inflammation therapies.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the RDY overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +12.3% vs the 50-day and +7.6% vs the 200-day average, 8.9% below the 52-week high and +25.3% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the RDY chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on RDY?

Recovery attempt under the 200-day — Trades +12.3% vs the 50-day and +7.6% vs the 200-day average, 8.9% below the 52-week high and +25.3% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is RDY above its 50-day and 200-day moving averages?

As of 2026-11-02, Dr. Reddy’s Laboratories Ltd ADR trades +12.3% above its 50-day and +7.6% above its 200-day average, with the 20-day +7.1% away.

How far is RDY from its 52-week high?

8.9% below the 52-week high and 25.3% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.